Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

KITT vs ISRG vs SYK vs OCEA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
KITT
Nauticus Robotics, Inc.

Aerospace & Defense

IndustrialsNASDAQ • US
Market Cap$2M
5Y Perf.-100.0%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+38.8%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$109.33B
5Y Perf.+20.6%
OCEA
Ocean Biomedical, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$6K
5Y Perf.-100.0%

KITT vs ISRG vs SYK vs OCEA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
KITT logoKITT
ISRG logoISRG
SYK logoSYK
OCEA logoOCEA
IndustryAerospace & DefenseMedical - Instruments & SuppliesMedical - DevicesBiotechnology
Market Cap$2M$159.85B$109.33B$6K
Revenue (TTM)$5M$10.58B$25.12B$0.00
Net Income (TTM)$-41M$2.98B$3.25B$-31M
Gross Margin-133.9%66.3%63.5%
Operating Margin-449.8%30.5%22.4%
Forward P/E43.3x19.1x
Total Debt$22M$303M$14.86B$16M
Cash & Equiv.$7M$3.37B$4.01B

KITT vs ISRG vs SYK vs OCEALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

KITT
ISRG
SYK
OCEA
StockNov 21May 26Return
Nauticus Robotics, … (KITT)1000.0-100.0%
Intuitive Surgical,… (ISRG)100138.8+38.8%
Stryker Corporation (SYK)100120.6+20.6%
Ocean Biomedical, I… (OCEA)1000.0-100.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: KITT vs ISRG vs SYK vs OCEA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG and SYK are tied at the top with 3 categories each — the right choice depends on your priorities. Stryker Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. KITT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
KITT
Nauticus Robotics, Inc.
The Growth Play

KITT is the clearest fit if your priority is growth exposure.

  • Rev growth 191.8%, EPS growth 96.8%, 3Y rev CAGR -22.7%
  • 191.8% revenue growth vs SYK's 11.2%
Best for: growth exposure
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 5.5% 10Y total return vs SYK's 179.2%
  • Lower volatility, beta 1.00, Low D/E 1.7%, current ratio 4.87x
  • 28.2% margin vs KITT's -7.7%
  • -16.4% vs OCEA's -98.0%
Best for: long-term compounding and sleep-well-at-night
SYK
Stryker Corporation
The Income Pick

SYK is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.

  • Dividend streak 34 yrs, beta 0.52, yield 1.2%
  • PEG 1.28 vs ISRG's 1.99
  • Beta 0.52, yield 1.2%, current ratio 1.89x
  • Better valuation composite
Best for: income & stability and valuation efficiency
OCEA
Ocean Biomedical, Inc.
The Secondary Option

OCEA lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthKITT logoKITT191.8% revenue growth vs SYK's 11.2%
ValueSYK logoSYKBetter valuation composite
Quality / MarginsISRG logoISRG28.2% margin vs KITT's -7.7%
Stability / SafetySYK logoSYKBeta 0.52 vs KITT's 2.94, lower leverage
DividendsSYK logoSYK1.2% yield; 34-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)ISRG logoISRG-16.4% vs OCEA's -98.0%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs OCEA's -19.4%

KITT vs ISRG vs SYK vs OCEA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

KITTNauticus Robotics, Inc.
FY 2022
Service
100.0%$11M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
OCEAOcean Biomedical, Inc.

Segment breakdown not available.

KITT vs ISRG vs SYK vs OCEA — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGOCEA

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

SYK and OCEA operate at a comparable scale, with $25.1B and $0 in trailing revenue. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to KITT's -7.7%. On growth, KITT holds the edge at +124.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
RevenueTrailing 12 months$5M$10.6B$25.1B$0
EBITDAEarnings before interest/tax-$21M$3.8B$6.3B-$29M
Net IncomeAfter-tax profit-$41M$3.0B$3.2B-$31M
Free Cash FlowCash after capex-$24M$2.8B$4.3B-$4M
Gross MarginGross profit ÷ Revenue-133.9%+66.3%+63.5%
Operating MarginEBIT ÷ Revenue-4.5%+30.5%+22.4%
Net MarginNet income ÷ Revenue-7.7%+28.2%+12.9%
FCF MarginFCF ÷ Revenue-4.5%+26.8%+17.1%
Rev. Growth (YoY)Latest quarter vs prior year+124.4%+23.0%+11.4%
EPS Growth (YoY)Latest quarter vs prior year+96.8%+18.8%+56.0%-162.5%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SYK leads this category, winning 4 of 7 comparable metrics.

At 34.0x trailing earnings, SYK trades at a 41% valuation discount to ISRG's 57.2x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.29x vs ISRG's 2.63x — a lower PEG means you pay less per unit of expected earnings growth.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
Market CapShares × price$2M$159.8B$109.3B$5,501
Enterprise ValueMkt cap + debt − cash$17M$156.8B$120.2B$16M
Trailing P/EPrice ÷ TTM EPS-0.03x57.19x33.98x-0.00x
Forward P/EPrice ÷ next-FY EPS est.43.35x19.06x
PEG RatioP/E ÷ EPS growth rate2.63x2.29x
EV / EBITDAEnterprise value multiple43.28x19.76x
Price / SalesMarket cap ÷ Revenue0.30x15.88x4.35x
Price / BookPrice ÷ Book value/share0.26x9.10x4.87x
Price / FCFMarket cap ÷ FCF64.18x25.53x
SYK leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-6 for KITT. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to KITT's 3.16x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs OCEA's 0/9, reflecting solid financial health.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
ROE (TTM)Return on equity-5.8%+16.9%+15.0%-98.8%
ROA (TTM)Return on assets-92.9%+14.8%+6.9%-19.4%
ROICReturn on invested capital-115.9%+15.0%+11.4%
ROCEReturn on capital employed-2.7%+16.5%+13.0%
Piotroski ScoreFundamental quality 0–95660
Debt / EquityFinancial leverage3.16x0.02x0.66x
Net DebtTotal debt minus cash$15M-$3.1B$10.8B$16M
Cash & Equiv.Liquid assets$7M$3.4B$4.0B
Total DebtShort + long-term debt$22M$303M$14.9B$16M
Interest CoverageEBIT ÷ Interest expense-3.68x6.72x-16.53x
ISRG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,174 today (with dividends reinvested), compared to $0 for OCEA. Over the past 12 months, ISRG leads with a -16.4% total return vs OCEA's -98.0%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.1% vs OCEA's -96.8% — a key indicator of consistent wealth creation.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
YTD ReturnYear-to-date-68.9%-19.9%-17.8%-84.6%
1-Year ReturnPast 12 months-96.9%-16.4%-24.5%-98.0%
3-Year ReturnCumulative with dividends-100.0%+48.5%+2.4%-100.0%
5-Year ReturnCumulative with dividends-100.0%+61.7%+17.5%-100.0%
10-Year ReturnCumulative with dividends-100.0%+549.2%+179.2%-100.0%
CAGR (3Y)Annualised 3-year return-92.6%+14.1%+0.8%-96.8%
ISRG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and SYK each lead in 1 of 2 comparable metrics.

SYK is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than KITT's 2.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 74.5% from its 52-week high vs OCEA's 1.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
Beta (5Y)Sensitivity to S&P 5002.94x1.00x0.52x1.10x
52-Week HighHighest price in past year$87.12$603.88$404.87$0.01
52-Week LowLowest price in past year$0.90$427.84$284.97$0.00
% of 52W HighCurrent price vs 52-week peak+2.5%+74.5%+70.5%+1.3%
RSI (14)Momentum oscillator 0–10029.143.626.645.0
Avg Volume (50D)Average daily shares traded560K1.8M2.1M32K
Evenly matched — ISRG and SYK each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: ISRG as "Buy", SYK as "Buy". Consensus price targets imply 38.3% upside for ISRG (target: $623) vs 36.5% for SYK (target: $390). SYK is the only dividend payer here at 1.18% yield — a key consideration for income-focused portfolios.

MetricKITT logoKITTNauticus Robotics…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…OCEA logoOCEAOcean Biomedical,…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60$389.62
# AnalystsCovering analysts5550
Dividend YieldAnnual dividend ÷ price+1.2%
Dividend StreakConsecutive years of raises34
Dividend / ShareAnnual DPS$3.36
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SYK leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

KITT vs ISRG vs SYK vs OCEA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is KITT or ISRG or SYK or OCEA a better buy right now?

For growth investors, Nauticus Robotics, Inc.

(KITT) is the stronger pick with 191. 8% revenue growth year-over-year, versus 11. 2% for Stryker Corporation (SYK). Stryker Corporation (SYK) offers the better valuation at 34. 0x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — KITT or ISRG or SYK or OCEA?

On trailing P/E, Stryker Corporation (SYK) is the cheapest at 34.

0x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, Stryker Corporation is actually cheaper at 19. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — KITT or ISRG or SYK or OCEA?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +61. 7%, compared to -100. 0% for Ocean Biomedical, Inc. (OCEA). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus OCEA's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — KITT or ISRG or SYK or OCEA?

By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.

52β versus Nauticus Robotics, Inc. 's 2. 94β — meaning KITT is approximately 462% more volatile than SYK relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 3% for Nauticus Robotics, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — KITT or ISRG or SYK or OCEA?

By revenue growth (latest reported year), Nauticus Robotics, Inc.

(KITT) is pulling ahead at 191. 8% versus 11. 2% for Stryker Corporation (SYK). On earnings-per-share growth, the picture is similar: Nauticus Robotics, Inc. grew EPS 96. 8% year-over-year, compared to -153. 2% for Ocean Biomedical, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — KITT or ISRG or SYK or OCEA?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -774. 0% for Nauticus Robotics, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -449. 8% for KITT. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is KITT or ISRG or SYK or OCEA more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Stryker Corporation (SYK) trades at 19. 1x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 24. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 38. 3% to $622. 60.

08

Which pays a better dividend — KITT or ISRG or SYK or OCEA?

In this comparison, SYK (1.

2% yield) pays a dividend. KITT, ISRG, OCEA do not pay a meaningful dividend and should not be held primarily for income.

09

Is KITT or ISRG or SYK or OCEA better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 2% yield, +179. 2% 10Y return). Nauticus Robotics, Inc. (KITT) carries a higher beta of 2. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +179. 2%, KITT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between KITT and ISRG and SYK and OCEA?

These companies operate in different sectors (KITT (Industrials) and ISRG (Healthcare) and SYK (Healthcare) and OCEA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KITT is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; OCEA is a small-cap quality compounder stock. SYK pays a dividend while KITT, ISRG, OCEA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

KITT

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 62%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

OCEA

Quality Business

  • Sector: Healthcare
  • Market Cap > $500M
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform KITT and ISRG and SYK and OCEA on the metrics below

Revenue Growth>
%
(KITT: 124.4% · ISRG: 23.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.